Ileocystoplasty in Dogs: Hematological and Biochemical Evaluation
World Small Animal Veterinary Association World Congress Proceedings, 2004
Ardeshir, A., Bakhtiari, J., Fattahian, H.R.
Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran

Bladder augmentation or Ileocystoplasty is addition of a bowel segment to the bladder in situ to increase capacity, improve compliance, and/or abate on controllable detrusor. This study was conducted to evaluate hematological and biochemical changes following Ileocystoplasty in dogs.

Twelve Persian mixed breed female dogs between 1-2 year-old and 15-24 kg body-weight were divided into control and experiment groups. Routine Ileocystoplasty was performed on experimental dogs. Blood samples were drawn for hematological and biochemical evaluations on days 0, 14 and 35 from all animals.

A mixed-model (repeated-measure) analysis of variance was used to compare the means of quantitative variables at different times. No significant changes were found in hematologic parameters (WBC, RBC, neutrophil, lymphocyte, monocyte, eosinophil, basophil, hematocrit, and platelets), glucose, cholesterol, triglyceride, creatinine, total protein, albumine, glutamine, serum electrolytes (calcium, potassium, phosphorus, sodium, chloride and bicarbonate), albumin, PH, blood gases (PO2 and PCO2) and anion gap. BUN was found significantly higher in experiment group in comparison to control group.

Routine ileocystoplasty found to have minimal effect on hematological and biochemical parameters and is recommended in reconstruction of diseased bladder.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

A. Ardeshir
Department of Clinical Sciences
Faculty of Veterinary Medicine, University of Tehran
Tehran, Iran


MAIN : Abstracts : Ileocystoplasty in Dogs
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.

CONTACT US

777 W. Covell Blvd., Davis, CA 95616

vingram@vin.com

PHONE

  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357
SAID=27